Skip to main content

Advertisement

SpringerLink
Log in

Churg-Strauss syndrome: 2005–2008 update

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Churg-Strauss syndrome (CSS) is a rare necrotizing small-vessel vasculitis associated with eosinophil-rich granulomatous inflammation of tissues and vessels and is also associated with asthma and eosinophilia. Epidemiologic studies continue to show that CSS is the rarest of the necrotizing small-vessel vasculitides. However, it is not possible to know with any certainty if there has been an increase in incidence. There has been an attempt to divide the patients with CSS into an antineutrophil cytoplasmic antibody-positive and cytoplasmic antibody-negative group. The former group has an increased frequency of renal involvement, parenchymal pulmonary disease, constitutional symptoms, and peripheral and central nervous system involvement, whereas the latter group has more frequent cardiac disease. The role of eosinophils and antineutrophil cytoplasmic antibodies remains poorly defined but provocative. Leukotriene receptor antagonists do not appear to induce CSS but facilitate the tapering of glucocorticoids, which unmasks the condition. Glucocorticoids and cyclophosphamide remain the foundation of treatment for vasculitis, but there are other promising and less toxic alternatives on the horizon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jennette JC, Falk RJ, Andrassy K, et al.: Nomenclature of systemic vasculitides-proposal of an international consensus conference. Arthritis Rheum 1994, 37:187–192.

    Article  PubMed  CAS  Google Scholar 

  2. Gross WL: Churg-Strauss syndrome: update on recent developments. Curr Opin Rheumatol 2002, 14:11–14.

    Article  PubMed  CAS  Google Scholar 

  3. Pagnoux C, Guilpain P, Guillevin L: Churg-Strauss syndrome. Curr Opin Rheumatol 2007, 19:25–32.

    Article  PubMed  Google Scholar 

  4. Noth I, Strek M, Leff A: Churg-Strauss syndrome. Lancet 2003, 361:587–594.

    Article  PubMed  Google Scholar 

  5. Lanham JG, Elkon KB, Pusey CD, Hughes GR: Systemic vasculitis with asthma an eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984, 63:65–81.

    Article  PubMed  CAS  Google Scholar 

  6. Masi AT, Hunder GG, Lie JT, et al.: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) Arthritis Rheum 1990, 33:1094–1100.

    PubMed  CAS  Google Scholar 

  7. Watts R, Lane S, Bentham G, et al.: Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000, 43:414–419.

    Article  PubMed  CAS  Google Scholar 

  8. Ormerod AS, Cook MC: Epidemiology of primary systemic vasculitis in the Australian Capital Territory and southeastern New South Wales. Intern Med J 2008 (in press).

  9. Mohammad AJ, Jacobsson LT, Mahr AD, et al.: Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology 2007, 46:1329–1337.

    Article  PubMed  CAS  Google Scholar 

  10. Sablé-Fourtassou R, Cohen P, Mahr A, et al.: Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005, 143:632–638.

    PubMed  Google Scholar 

  11. Sinico RA, Di Toma L, Maggiore U, et al.: Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005, 52:2926–2935.

    Article  PubMed  CAS  Google Scholar 

  12. Hellemans S, Dens J, Knockaert D: Coronary involvement in the Churg-Strauss syndrome. Heart 1997, 77:576–578.

    PubMed  CAS  Google Scholar 

  13. Pela G, Tirabassi G, Patteroneri P, et al.: Cardiac involvement in the Churg-Strauss syndrome. Am J Cardiol 2006, 97:1519–1524.

    Article  PubMed  Google Scholar 

  14. Baccouche H, Yilmaz A, Alscher D, et al.: Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome. Circulation 2008, 117:1745–1749.

    Article  PubMed  Google Scholar 

  15. Sinico RA, DiTomi L, Maggiore U, et al.: Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 2006, 47:770–779.

    Article  PubMed  Google Scholar 

  16. Sartori M, Briani C, Munari M, et al.: Cerebral venous thrombosis as a rare onset of Churg-Strauss syndrome. Thomb Haemost 2006, 96:90–92.

    CAS  Google Scholar 

  17. Aries PM, Gross WL: Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases. J Rheumatol 2006, 33:636.

    PubMed  Google Scholar 

  18. Matsuo S, Sato Y, Matsumoto T, et al.: Churg-Strauss syndrome presenting with massive pericardial effusion. Heart Vessels 2007, 22:128–130.

    Article  PubMed  Google Scholar 

  19. Boin F, Sciubba JJ, Stone JH: Churg-Strauss syndrome presenting with salivary gland enlargement and respiratory distress. Arthritis Rheum 2006, 55:167–170.

    Article  PubMed  Google Scholar 

  20. Matsushima H, Takayanagi N, Kurashima K, et al.: Multiple tracheobronchial mucosal lesions in two cases of Churg-Strauss syndrome. Respirology 2006, 11:109–112.

    Article  PubMed  Google Scholar 

  21. Wagner AD, Meyer GP, Rihl M, et al.: Acute coronary syndrome associated with Churg Strauss syndrome. Vasc Health Risk Manag 2007, 3:775–779.

    PubMed  Google Scholar 

  22. Skrapari I, Kagkelari E, Charitatos E, et al.: Acute painless monocular visual loss due to central retinal artery occlusion in a patient with Churg-Strauss vasculitis. Clin Rheumatol 2008, 27:125–127.

    Article  PubMed  Google Scholar 

  23. Türkçüoglu P, Isik A, Deniz N, et al.: Central retinal artery occlusion in an ANCA- negative Churg-Strauss syndrome patient. Int Ophthalmol 2007, 27:369–371.

    Article  PubMed  Google Scholar 

  24. Margolis R, Kosmorsky GS, Lowder CY: Conjunctival involvement in Churg-Strauss syndrome. Ocular Immunol Inflamm 2007, 15:113–115.

    Article  Google Scholar 

  25. Del Pero MM, Moffat D, Sudhoff H: Unusual presentation of temporal bone involvement in Churg-Strauss syndrome. J Laryngol Otolaryngol 2008, 122:425–427.

    Google Scholar 

  26. Guilpain P, Auclair JF, Tamby MC, et al.: Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome. Ann NY Acad Sci 2007, 1107:392–399.

    Article  PubMed  CAS  Google Scholar 

  27. Tsukadaira A, Okubo Y, Kitano K, et al.: Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc 1999, 20:39–44.

    Article  PubMed  CAS  Google Scholar 

  28. Kallenberg CG: Churg-Strauss syndrome: just one disease entity? Arthritis Rheum 2005, 52:2589–2593.

    Article  PubMed  Google Scholar 

  29. Matsuyama W, Mitsuyama H, Ono M, et al.: Discoidin domain receptor 1 contributes to eosinophil survival in an NF-κB-dependent manner in Churg-Strauss syndrome. Blood 2007, 109:22–30.

    Article  PubMed  CAS  Google Scholar 

  30. Polzer K, Karonitsch T, Neumann T, et al.: Eotaxin-3 is involved in Churg-Strauss syndrome-a serum marker closely correlating with disease activity. Rheumatology 2008, 47:804–808.

    Article  PubMed  CAS  Google Scholar 

  31. Tsurikisawa N, Saito H, Tsuburai T, et al.: Difference in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma. J Allergy Clin Immunol 2008, 122:610–616.

    Article  PubMed  CAS  Google Scholar 

  32. Kiene M, Csernock E, Muller A, et al.: Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum 2001, 44:469–473.

    Article  PubMed  CAS  Google Scholar 

  33. Guida G, Vallaro A, Stella S, et al.: Clonal CD8+ TCR-Vβ expanded populations with effector memory phenotype in Churg-Strauss Syndrome. Clin Immunol 2008, 128:94–102.

    Article  PubMed  CAS  Google Scholar 

  34. Vaglio A, Martorana D, Maggiore U, et al.: HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 2007, 56:3159–3166.

    Article  PubMed  CAS  Google Scholar 

  35. Wieczorek S, Hellmich B, Gross WL, Epplen JT: Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides. Arthritis Rheum 2008, 58:329–330.

    Article  PubMed  CAS  Google Scholar 

  36. Mitsuyana H, Matsuyama W, Iwakawa J, et al.: Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome. Chest 2006, 129:407–411.

    Article  Google Scholar 

  37. Woywodt A, Goldberg C, Kirsch T, et al.: Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA-associated vasculitis. Ann Rheum Dis 2006, 65:164–168.

    Article  PubMed  CAS  Google Scholar 

  38. Taira T, Matsuyama W, Mitsuyama H, et al.: Increased serum high mobility group box-1 level in Churg-Strauss syndrome. Clin Exp Immunol 2007, 148:241–247.

    Article  PubMed  CAS  Google Scholar 

  39. Serna-Candel C, Moreno-Perez O, Soriano V, Martinez A: Churg-Strauss syndrome triggered by hyposensitization to Alternaria fungus. Clin Rheumatol 2007, 26:2195–2196.

    Article  PubMed  CAS  Google Scholar 

  40. Lane S, Watts RA, Bentham G, et al.: Are environmental factors important in primary systemic vasculitis? A casecontrol study. Arthritis Rheum 2003, 48:814–823.

    Article  PubMed  Google Scholar 

  41. Keogh KA, Specks U: Churg-Strauss Syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003, 115:284–290.

    Article  PubMed  CAS  Google Scholar 

  42. Cuchacovich M, Justiniano M, Espinoza LR: Churg-Strauss syndrome associated with leukotrine receptor antagonists (LTRA). Clin Rheumatol 2007, 26:1769–1771.

    Article  PubMed  CAS  Google Scholar 

  43. Harrold LR, Patterson MK, Andrade SE, et al.: Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf 2007, 16:620–626.

    Article  PubMed  Google Scholar 

  44. Wieczorek S, Hellmich B, Arning L, et al.: Functionally relevant variations of the IL-10 gene associated with antineutrophil cytoplasmatic antibody-negative Churg-Strauss syndrome, but not with Wegener’s granulomatosis. Arthritis Rheum 2008, 58:1839–1848.

    Article  PubMed  CAS  Google Scholar 

  45. Gayraud M, Guillevin L, le Toumelin P, et al.: Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. French Vasculitis Study Group. Arthritis Rheum 2001, 44:666–675.

    Article  PubMed  CAS  Google Scholar 

  46. Ribi C, Cohen P, Pagnoux C, Mahr A: Treatment of Churg-Strauss syndrome without poor-prognosis factors. Arthritis Rheum 2008, 58:586–594.

    Article  PubMed  CAS  Google Scholar 

  47. Martinez V, Cohen P, Pagnoux P, et al.: Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies. Arthritis Rheum 2008, 58:308–317.

    Article  PubMed  CAS  Google Scholar 

  48. Taniguchi M, Tsurikisawa N, Higashi N: Treatment of Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy. Allergol Int 2007, 56:97–103.

    Article  PubMed  CAS  Google Scholar 

  49. Danieli MG, Cappelli M, Malcangi G, et al.: Long term effectiveness of intravenous immunoglobulin in Churg-Straus syndrome. Ann Rheum Dis 2004, 63:1649–1654.

    Article  PubMed  CAS  Google Scholar 

  50. Hot A, Perard L, Coppere, et al.: Marked improvement of Churg-Strauss vasculitis with intravenous gamma globulins during pregnancy. Clin Rheumatol 2007, 26:2149–2151.

    Article  PubMed  Google Scholar 

  51. Simon HU, Seelbach H, Ehmann R, Schmitz M: Clinical and immunological effects of low dose IFN-α treatment in patients with corticosteroid-resistant asthma. Allergy 2003, 58:1250–1255.

    Article  PubMed  CAS  Google Scholar 

  52. Metzler C, Lamprecht P, Reuter M, et al.: Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon (alpha). Ann Rheum Dis 2005, 64:1242–1243.

    Article  PubMed  CAS  Google Scholar 

  53. Goblin JM, Specks U: Targeting B lymphocytes as therapy for ANCA-associated vasculitis. Rheum Disc Clin North Am 2007, 33:741–754.

    Article  Google Scholar 

  54. Eriksson P: Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 2005, 257:540–548.

    Article  PubMed  CAS  Google Scholar 

  55. Smith KG, Jones RB, Burns SM, Jayne DR: Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse and retreatment. Arthritis Rheum 2006, 54:2970–2982.

    Article  PubMed  CAS  Google Scholar 

  56. Koukoulaki M, Smith KG, Jayne DR: Rituximab in Churg-Strauss syndrome. Ann Rheum Dis 2006, 65:557–559.

    Article  PubMed  CAS  Google Scholar 

  57. Kaushik VV, Reddy HV, Bucknall RC: Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome. Ann Rheum Dis 2006, 65:1116–1117.

    Article  PubMed  CAS  Google Scholar 

  58. Bartolucci P, Ramanoelina J, Cohen P, et al.: Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology 2002, 41:1126–1132.

    Article  PubMed  CAS  Google Scholar 

  59. Booth A, Harper L, Hammad T, et al.: Prospective study of TNFα blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Ann Soc Nephrol 2004, 15:717–721.

    Article  CAS  Google Scholar 

  60. Wegener’s Ganulomatosis Etanercept Trial (WGET) Research Group: Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med 2005, 352:351–356.

    Article  Google Scholar 

  61. Bargagli E, Madioni C, Oliveri C, et al.: Churg-Strauss vasculitis in a patient treated with omalizumab. J Asthma 2008, 45:115–116.

    Article  PubMed  CAS  Google Scholar 

  62. Ruppert AM, Averous G, Stanciu D, et al.: Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment. J Allergy Clin Immunol 2008, 121:253–254.

    Article  PubMed  CAS  Google Scholar 

  63. Bianchi PG, Bianchi MG, Agondi R, et al.: Administration of anti-IgE to a Churg-Strauss syndrome patient. Int Arch Allergy Immunol 2007, 144:155–158.

    Article  Google Scholar 

  64. Bianchi PG, Agondi R, Kalil J: One year administration of anti-IgE to a patient with Churg-Strauss syndrome. Int Arch Allergy Immunol 2008, 146:176

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Indiana University School of Medicine, 1110 W. Michigan Street, LO-545, Indianapolis, IN, 46202, USA

    Rafael G. Grau

Authors
  1. Rafael G. Grau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rafael G. Grau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grau, R.G. Churg-Strauss syndrome: 2005–2008 update. Curr Rheumatol Rep 10, 453–458 (2008). https://doi.org/10.1007/s11926-008-0074-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-008-0074-x

Keywords

Search

Navigation